Коликид

Quick links to important sections

Коликид

Selected form

Method of action: Antispasmodic

Treatment option: Dyspepsia, Flatulence

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Коликид

Quick Facts

Property Description
Active ingredient Simethicone (Simeticone INN)
Form Oral Suspension, Film-Coated Tablets
Pharmacological class Antiflatulent Agent
Common use Relief of gas-related bloating and pressure
Origin Synthetic Compound (Silicone)

What Type of Medicine is Коликид? (Classification and Origin)

Коликид is an antiflatulent agent primarily classified as a specialized gastrointestinal agent, commonly used for the discomfort associated with excess gas in the digestive tract. Its active principle is the single-ingredient compound, Simethicone (Simeticone INN), which is a synthetic compound derived from the silicone chemical class. The medication is characterized as a non-systemic agent, meaning it acts only locally within the gastrointestinal lumen and is not systemically absorbed into the body.

This medicine, often available Over-the-Counter (OTC), specifically addresses the physical symptom of gas pressure. Unlike prescription drugs that target inflammatory processes or motility disorders, Коликид uses a physical method of action, making it suitable for a wide patient demographic.

Composition and General Purpose (Physical Action)

The core active ingredient, Simethicone, is chemically composed of a mixture of polydimethylsiloxane and silicon dioxide. The general therapeutic purpose of this formulation is to relieve the uncomfortable feelings of pressure, bloating, and abdominal distension caused by flatulence.

Simethicone achieves this relief by acting as a non-systemic surfactant or defoaming agent within the gut. Its mechanism involves reducing the surface tension of trapped gas bubbles, causing them to break down and merge (coalescence) into larger gas pockets that are easily eliminated. This physical action facilitates the natural expulsion of gas from the body via burping or flatulence.

Available Forms: Oral Suspension and Tablets

Коликид is available in two distinct dosage forms for oral administration: an oral suspension (liquid form) and film-coated tablets. The provision of the oral suspension is designed to cater to the infant and small children target audience who require a palatable liquid solution. Conversely, the film-coated tablets are available for older patients, including teenagers and adults, ensuring accessible delivery across all relevant age groups.

Regulatory References

  1. StatPearls/Simethicone
  2. Simethicone (DrugBank)

What side effects are possible with Коликид?

Possible side effects and safety information

The safety profile of Коликид (Simethicone) is determined by its non-systemic nature, meaning the active ingredient is not absorbed into the bloodstream but acts locally within the gastrointestinal tract. This physical action accounts for the limited scope of officially documented adverse reactions.


Officially Documented Adverse Reactions

The primary adverse effects associated with this agent are related to hypersensitivity.

Category Regulatory Status
Frequency Not Known (Cannot be estimated from available data, typically post-marketing reports).
System-Organ Classes Immune System Disorders; Skin and Subcutaneous Tissue Disorders.
Adverse Reactions Rash, Pruritus, and mild Gastrointestinal Disturbances.

Serious adverse reactions are rare but include severe manifestations of hypersensitivity, such as angioedema and face edema, as documented in regulatory safety summaries.


Safety Restrictions and Considerations

Official regulatory documents specify safety limitations for the use of Simethicone. The medicine is contraindicated in individuals with a known or suspected intestinal obstruction or intestinal perforation. It is also contraindicated in cases of known hypersensitivity to Simethicone or any of the product's excipients.

Due to the lack of systemic absorption, Simethicone is generally considered appropriate for use in pediatric patients, including infants, and typically requires no specific dose adjustments or additional safety warnings for older adults or individuals with renal or hepatic impairment. This safety structure is consistent with the compound’s inert, localized action.

Overdose and Emergency Response

Overdose Map: Overdose and when to seek help — Official Regulatory Information for Коликид


Overdose Scope

Category Official Regulatory Statement
Documented overdose presentations: Regulatory documentation states that no case of overdose has been reported. The sole theoretical manifestation cited is constipation
Physiological systems affected (as stated in label): Primarily the gastrointestinal tract. The substance is confirmed as physiologically inert and not absorbed systemically, precluding documentation of systemic effects.
Dose-related or exposure-related factors (if applicable): No specific dose levels are officially documented to cause severe systemic effects.
Population-specific overdose notes (if applicable): Prompt medical attention is critical for adults as well as children.
Emergency-response statements (as written in official documents): Seek immediate medical attention.
When immediate medical help is required (label-derived phrasing only): Contact a Poison Control Center right away.

Overdose Classifications (High-Level)

Category Official Regulatory Statement
Severity classification (as defined in official documents): Generally considered low risk for systemic toxicity due to the non-absorbable, inert nature of the active ingredient.
Regulatory basis (EMA / FDA / etc.): Information is based on SmPC and FDA DailyMed prescribing information.
Overdose-context constraints (as defined in official documents): Treatment is limited to symptomatic and supportive measures.

Resulting Overdose Structure

Official Overdose Statements:

  • The substance is described as physiologically inert and not systemically absorbed, resulting in no reported cases of overdose in major regulatory documentation.
  • Management of a theoretical overdose is described as symptomatic and supportive treatment, including treating with fluids and a requirement to keep under observation.
  • Regulatory authorities mandate that for any suspected overdose, individuals must seek immediate medical attention and contact a Poison Control Center right away.

Connection to the overall overdose profile (2–4 sentences): The regulatory overdose profile for Коликид is defined by the absence of systemic toxicity, given the substance's inert nature. Consequently, official documents focus on the procedural requirement to seek immediate medical attention for all suspected cases, which is deemed critical for adults as well as children. This structure underscores that the primary documented management steps are observation and general supportive measures, with no specific antidote known.

Therapeutic Uses of Коликид

Key Symptomatic Domains

This ingredient is used to help manage the symptoms of gas, including uncomfortable pressure, a feeling of fullness, and visible abdominal distension (bloating).

Коликид is applied across domains where supportive symptom management is appropriate for symptoms related to physical discomfort, primarily addressing issues associated with aerophagia, flatulence, and gas-related pain in functional conditions like Irritable Bowel Syndrome (IBS) or Functional Dyspepsia. This supportive relief may help patients cope more steadily with symptom fluctuations and supports general well-being during symptomatic phases.


Clinical and Contextual Use

This medicine is relevant in contexts involving episodic or fluctuating manifestations, often used during phases when symptoms become more noticeable. Common clinical scenarios include postoperative care to manage gas pain after abdominal surgery, and use in pediatric patients (infants and small children) to address gas-related fussiness. Furthermore, it is applied when appropriate prior to gastroscopy or radiography to assist with visualization.

Quick Fact: Relief for Pressure
Symptom Focus Abdominal pressure, bloating, and distension.
Therapeutic Benefit Contributes to improved day-to-day comfort during symptomatic periods.

Regulatory References

  1. NIH MedlinePlus Drug Information

Eligibility and Restrictions for Use

Official Eligibility Profile for Коликид (Simethicone)

The regulatory eligibility for Коликид, which contains Simethicone, is broad due to its status as a non-systemic agent that is not absorbed into the bloodstream. This property permits use across various patient demographics.


Populations Allowed or Permitted

Use is permitted across the entire life spectrum, including Adults, Teenagers, Children (2–12 years), and Infants (under 2 years). The medicine is also permitted for use during both pregnancy and breastfeeding as no fetal or infant exposure is anticipated.


Absolute Contraindications

Use is contraindicated in patients with a known hypersensitivity (allergy) to Simethicone or any other ingredient in the formulation. Use is also contraindicated in patients with suspected or known gastrointestinal (GI) perforation or GI obstruction.


Eligibility-Related Restrictions

Some regulators state that Simethicone is not recommended for the specific treatment of infant colic due to limited information on established efficacy for that specific indication. For certain comorbidities, such as rare glucose-galactose malabsorption, use may be conditionally restricted, depending on the specific excipients present in the product formulation.

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section describes officially documented interaction patterns based on regulatory prescribing information for Simethicone, the active ingredient in Коликид.

The interaction profile of this medicine is largely defined by its non-systemic nature, meaning it is not absorbed into the body and therefore lacks involvement in metabolic or systemic drug interactions. Regulatory documentation does not report interactions involving CYP enzymes, drug transporters, or pharmacodynamic effects with other medicines.

Documented Physical Absorption Interference

The only formally documented interaction involves a physical absorption interference with thyroid replacement hormones.

Interacting Product Category Official Outcome and Restriction
Levothyroxine (and related thyroid hormones) Co-administration may decrease the oral bioavailability and reduce the exposure of the thyroid hormone.

Administration Timing Rule

Due to this absorption effect, official regulatory labeling requires a specific separation of administration time. When co-administration is necessary, Levothyroxine must be administered at least four hours before or after the Simethicone-containing product.

Absence of Other Documented Interactions

No medicinal products are formally classified as contraindicated for co-administration. Furthermore, official government labeling does not specify any known interactions with food, alcohol, or herbal products.

Mechanism of Action

The Physical Mechanism: Surface Tension Reduction and Defoaming

The mechanism of Simethicone is based on a physical process and is pharmacologically inert, meaning it does not interact with the body's biochemical machinery (receptors, enzymes, or transporters). The active ingredient operates as an inert surfactant strictly within the gastrointestinal lumen, maintaining its non-systemic state as it is not absorbed. The primary mechanistic domain involves the reduction of surface tension at the gas-liquid interface, which surrounds the small, numerous gas bubbles forming foam. This physical action directly destabilizes the foam structure and initiates the disintegration of the gas-liquid foam mass.


Mechanistic Cascade: Coalescence and Facilitated Gas Elimination

The mechanistic cascade begins once the small bubbles are ruptured by the reduction in surface tension, causing them to merge rapidly (coalesce) into larger, free-moving gas pockets . The formation of these large pockets renders the gas volume accessible to natural physiological discharge processes, such as eructation or flatulence. This facilitated expulsion constitutes the core physiological change, resulting in the elimination of the gas volume from the digestive tract.

Dosage and Administration Information

How to Use Коликид: Official Administration Guidelines

Коликид (Simethicone) is administered according to a non-systemic use protocol that follows guidance regarding dose, frequency, and preparation.


Administration Scope

Feature Guideline (Strictly Label-Based)
Route of Administration The only approved method is Oral administration, as the medicine is designed to act locally within the gastrointestinal tract.
Dosing Schedule Adults and children over 12 typically use unit doses ranging from 40 mg to 125 mg. The label specifies a maximum daily dose that must not be exceeded, often stated at 500 mg to 600 mg over a 24-hour period.
Timing in Relation to Meals Dosing is usually recommended to occur after meals (post-prandially) and, if needed, a final dose is taken at bedtime.
Preparation Requirements The oral suspension (liquid form) must be shaken well immediately before measuring to ensure the active ingredient is uniformly dispersed. Accurate measurement with a calibrated dropper is required.

Administration Protocol

Age-Group Administration Rules: The official protocol defines distinct, lower dose ranges of 20 mg to 40 mg for the pediatric population (infants and small children), for whom the liquid suspension is the preferred form of delivery. No systemic dose adjustments are specified for renal or hepatic impairment due to the drug's non-absorbed nature.

Frequency Pattern: Administration is classified as as-needed (PRN) or intermittent, typically up to four times per day (QID) for symptom relief.

Special Procedural Conditions: Simethicone is also officially administered in a single, dedicated high dose prior to diagnostic procedures such as endoscopy or ultrasonography to assist with visualization by reducing gas bubbles.

These instructions collectively define the officially sanctioned pattern of use, setting constraints on how much and how often the medicine is used.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Коликид


Evidence for use in Studies Related to Infant Colic

Research has primarily examined Коликид's use in infants experiencing conditions characterized by fluctuating or episodic manifestations of colic. Studies often compare the patterns observed in infants using Коликид against those receiving a non-active substitute, with the aim of observing and tracking changes in outcomes describing episodic or acute changes in crying time.

In studies conducted during periods of increased symptom activity, research so far indicates patterns related to changes in infant crying and fussiness. However, the findings were mixed across different trials; while some evidence suggests a positive change in patient-reported outcomes describing perceived discomfort, other studies did not report a significant difference. It is important to remember that findings describe group patterns, not personal outcomes, and results apply only to the populations studied.


Evidence for use in Studies Related to Digestive Comfort

In addition to its use in infants with acute distress, Коликид was evaluated in studies where the focus was on general outcomes related to systemic or functional imbalance in the infant gut. This research explores patterns related to a balanced gut environment and overall digestive well-being, by examining factors like gut microflora changes.

The research highlights changes measured during the study period related to the digestive environment. However, the connection between these measured changes and the infant's day-to-day well-being appears to be complex and evidence is limited.


What is Still Uncertain About Коликид

A key area of uncertainty is the mixed findings reported across studies, particularly when comparing outcomes related to physical discomfort. This makes it difficult to draw a consistent conclusion about the full extent of the product's effect, highlighting that evidence quality varies across studies.

Currently, long-term effects are not fully established, and follow-up durations were limited in most research. Furthermore, comparative evidence is lacking to fully understand how the product performs against other available interventions. Research is ongoing to further contribute to the broader evidence landscape.

Key Studies & References

  1. Infantile Colic: Recognition and Management. Guideline by the National Institute for Health and Care Excellence (NICE)

Frequently Asked Questions (FAQ)

Common questions about Коликид (FAQ)


Q: How quickly does the effect of Коликид usually start?

A: Official information describes the active ingredient, Simethicone, as having a short duration of action. Its physical mechanism works rapidly by quickly breaking up gas bubbles in the digestive tract. Therefore, relief from acute symptoms is often described as occurring shortly after administration, consistent with the product's rapid physical action.


Q: Is Коликид the same as other similar products I see advertised?

A: Коликид contains Simethicone as its only active ingredient, which is classified as an antiflatulent agent. Many other over-the-counter products marketed for gas and bloating relief also use Simethicone as their primary active component. The differences often lie in the formulation (e.g., drops vs. tablets) or the non-active ingredients.


Q: Is Коликид suitable for use by children?

A: Yes, official eligibility documents confirm that Simethicone is permitted for use in pediatric patients, including infants and children, as it is not absorbed into the body. However, some regulatory bodies note that it is not recommended for the specific treatment of infant colic due to limited established evidence of effectiveness for that condition.


Q: Are the side effects of Коликид usually mild?

A: The safety profile is generally considered favorable because the medicine is not absorbed into the bloodstream. The most common adverse reactions listed in official documents are mild gastrointestinal disturbances and signs of hypersensitivity like rash. While rare, more serious hypersensitivity events, such as facial swelling (angioedema), have been documented in safety summaries.


Q: What does the patient information leaflet say about alcohol use with Коликид?

A: Due to its non-systemic action (meaning it is not absorbed into the body), regulatory guidance and patient information generally state that no known interactions exist between Simethicone and alcohol. Referencing the official patient leaflet is the recommended way to find specific guidance.


Q: Can I take Коликид with common pain relievers?

A: Simethicone's non-systemic nature means it is typically not associated with systemic interactions with most other medicines. Databases indicate no major interactions reported with common non-prescription pain relievers. The only formally documented concern is with thyroid hormones (e.g., Levothyroxine), which require separated administration times.


Q: What is the general recommended period for using Коликид?

A: Official documents describe the medicine for as-needed (PRN) use in response to symptoms. The product label does not typically approve the medicine for indefinite use. Patients are generally advised in product labels to seek medical advice if symptoms persist or worsen after using the drug for a set period, often specified as a few days.


Q: What should I do if I accidentally miss a time I was supposed to take Коликид?

A: Patient information typically outlines a protocol for missed administration, which varies depending on the time of the next intended dose. The general rule is that double dosing is generally advised against by official guidance.


Q: Do you have to take Коликид at a specific time of day?

A: The dosing is classified as as-needed for symptom relief, rather than requiring a rigid daily schedule. Official guidance recommends administration after meals and, if needed, a final dose at bedtime, as these timings align with periods when gas-related symptoms often occur.


Q: Are there different strengths or versions of Коликид available?

A: Yes, regulatory databases confirm that products containing Simethicone are marketed in multiple dosage forms, including oral suspension (liquid) and various strengths of tablets or capsules. These different forms are available to suit various patient groups and administration needs.


Q: What does official information say about using Коликид long-term?

A: Official documents designate the medicine for as-needed use for acute symptoms. Product labeling does not typically approve the medicine for continuous or indefinite long-term use. Patients are generally instructed to consult a healthcare provider if symptoms persist for several days.


Q: Is there a known possibility of Коликид causing dependence?

A: The active ingredient, Simethicone, is a non-systemic agent that is not absorbed into the body and is pharmacologically inert. Because of this, regulatory safety reviews have not identified any known reports or formal warnings indicating that the use of this medicine leads to physical dependence.


Q: Is there any research looking into how Коликид affects different age groups?

A: Official research evidence primarily focuses on the use of the medicine in infants and their colic-related symptoms. The basis for use in adults and older children relies on the general non-systemic safety profile and the established physical action of Simethicone in reducing gas.


Q: Does Коликид require any special instructions for traveling?

A: Official storage instructions require the medicine to be stored below 25 C and protected from freezing. While no specific travel instructions are provided, avoiding extreme heat or cold and keeping the product sealed in its original container are necessary to maintain product stability.


Q: Is a generic version of Коликид available?

A: The active ingredient in Коликид is Simethicone, which is available as a generic substance or in many non-brand name, over-the-counter products globally. The availability of a direct generic equivalent of a specific brand name product depends on local market regulations.


Q: Is Коликид commonly used in other countries besides [local context country]?

A: The active ingredient, Simethicone, is a globally recognized pharmaceutical-grade compound that is compliant with major international regulatory benchmarks. This compliance indicates the substance has widespread acceptance and common use in many countries for treating gas-related symptoms.


Q: Are there any specific organs or body systems that Коликид is known to affect?

A: The official mechanism of action is localized entirely to the gastrointestinal lumen (the inside of the gut). As a non-systemic agent, Simethicone is not absorbed into the bloodstream and therefore does not affect body systems or organs outside of the digestive tract.


Q: Is the action of Коликид permanent or temporary?

A: The medicine is classified as having a short duration of action and provides temporary relief from acute gas symptoms. Because the ingredient is eliminated from the body via the feces without being absorbed, its physical effect is limited to the time it is present in the digestive tract and is not permanent.


Q: Can the effectiveness of Коликид be affected by diet?

A: Patient information sometimes notes that foods or drinks that increase stomach gas may counteract the product's defoaming action. Official documentation specifies that use is recommended after meals, aligning with periods when gas-related symptoms often occur.


Q: Is it okay to crush or chew the Коликид form (if applicable)?

A: Instructions depend on the dosage form. The preparation instructions for chewable tablets specify that they are designed to be chewed completely before swallowing. Conversely, film-coated tablets or capsules are typically designed to be swallowed whole and are not recommended to be altered.


Q: Are there any known issues with taking Коликид and driving or operating machinery?

A: Due to its non-systemic nature and lack of action on the central nervous system, official safety advice generally confirms that Simethicone is not expected to affect a person's ability to drive or operate heavy machinery.


Q: Is it possible for Коликид to interfere with laboratory tests?

A: Simethicone is officially administered in a dedicated dose prior to certain diagnostic procedures like endoscopy or ultrasound. Its known action is to reduce gas bubbles and improve visualization, meaning it is used to aid diagnostic tests rather than interfere with them.

How should Коликид be stored and disposed of?

How to Store and Dispose of Коликид?

The storage and disposal of Коликид (Simethicone oral drops) are defined by official regulatory labeling to ensure product stability and safety.


Storage Conditions

Regulatory requirements mandate that the medicine must be stored below 25 C and protected from freezing. It is necessary to keep the bottle tightly closed and always use the original container. The medicine must be stored out of the sight and reach of children.

Stability Limit: After the bottle is first opened, the product's usable shelf-life is 28 days.


Disposal Requirements

Unused or expired medicine must be disposed of according to local requirements. To protect the environment, the product must not be discarded via wastewater or household waste, and should be taken to a designated collection point.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Коликид found in:

A-Z Index: